Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for SARTORIUS (SSSGY : OTC)
 
 • Company Description   
Sartorius AG is a pharmaceutical and laboratory equipment supplier. The company manufactures equipment for biomolecular and microbial separations, cell culture, concentration, fermentation and purification. Sartorius AG is headquartered in Goettingen, Germany.

Number of Employees: 14,042

 
 • Price / Volume Information   
Yesterday's Closing Price: $43.93 Daily Weekly Monthly
20 Day Moving Average: 0 shares
Shares Outstanding: 171.19 (millions)
Market Capitalization: $7,520.95 (millions)
Beta: 0.83
52 Week High: $50.95
52 Week Low: $39.45
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 0.00% 0.45%
12 Week 0.00% -2.13%
Year To Date -2.37% -13.42%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
OTTO-BRENNER-STRASSE 20
-
GOETTINGEN,2M 37079
DEU		 ph: 49-55-130-80
fax: 49-55-1308-3289		 ben.orzelek@sartorius.com http://www.sartorius.com
 
 • General Corporate Information   
Officers
Joachim Kreuzburg - Chief Executive Officer and Chairman
Florian Funck - Chief Financial Officer
Rene Faber - Member of the Executive Board
Alexandra Gatzemeyer - Member of the Executive Board
Rainer Lehmann - Member of the Executive Board

Peer Information
SARTORIUS (ABMD)
SARTORIUS (DMDS)
SARTORIUS (CPWY.)
SARTORIUS (EQUR)
SARTORIUS (ECIA)
SARTORIUS (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 80385Q109
SIC: 3843
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 06/01/26
Next Expected EPS Date: 10/15/26
Share - Related Items
Shares Outstanding: 171.19
Most Recent Split Date: 1.00 (5.00:1)
Beta: 0.83
Market Capitalization: $7,520.95 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.21%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.09
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 10/15/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: 43.67
PEG Ratio: -
Price Ratios
Price/Book: 1.62
Price/Cash Flow: 8.85
Price / Sales: 1.80
EPS Growth
vs. Year Ago Period: 8.70%
vs. Previous Quarter: 7.14%
Sales Growth
vs. Year Ago Period: 5.65%
vs. Previous Quarter: 0.75%
ROE
06/30/26 - 7.57
03/31/26 - 7.53
12/31/25 - 7.56
ROA
06/30/26 - 3.04
03/31/26 - 2.95
12/31/25 - 2.94
Current Ratio
06/30/26 - 1.14
03/31/26 - 0.91
12/31/25 - 0.90
Quick Ratio
06/30/26 - 0.56
03/31/26 - 0.52
12/31/25 - 0.50
Operating Margin
06/30/26 - 8.16
03/31/26 - 8.07
12/31/25 - 8.12
Net Margin
06/30/26 - 5.50
03/31/26 - 4.61
12/31/25 - 4.38
Pre-Tax Margin
06/30/26 - 11.33
03/31/26 - 9.85
12/31/25 - 9.52
Book Value
06/30/26 - 27.15
03/31/26 - 26.60
12/31/25 - 25.56
Inventory Turnover
06/30/26 - 2.39
03/31/26 - 2.40
12/31/25 - 2.39
Debt-to-Equity
06/30/26 - 0.91
03/31/26 - 0.86
12/31/25 - 0.87
Debt-to-Capital
06/30/26 - 47.72
03/31/26 - 46.17
12/31/25 - 46.46
 

Powered by Zacks Investment Research ©